Aspirin News and Research

RSS
Aspirin also known as acetylsalicylic acid is a salicylate drug, often used as an analgesic to relieve minor aches and pains, as an antipyretic to reduce fever, and as an anti-inflammatory medication. Aspirin also has an antiplatelet, or "anti-clotting", effect and is used in long-term, low doses to prevent heart attacks, strokes and blood clot formation in people at high risk for developing blood clots. It has also been established that low doses of aspirin may be given immediately after a heart attack to reduce the risk of another heart attack or of the death of cardiac tissue.
Care for Asian-American heart attack patients gets better

Care for Asian-American heart attack patients gets better

Grief and heart attacks linked: Study

Grief and heart attacks linked: Study

Trail of research that led to discovery of aspirin's role in prevention of first heart attack

Trail of research that led to discovery of aspirin's role in prevention of first heart attack

Cannabis Science extracts benefit squamous cell carcinoma cancer and skin cancer patients

Cannabis Science extracts benefit squamous cell carcinoma cancer and skin cancer patients

FDA approves Infrascanner to detect life-threatening brain bleeding

FDA approves Infrascanner to detect life-threatening brain bleeding

Second-hand smoke exposure during childhood associated with aspirin-exacerbated respiratory disease

Second-hand smoke exposure during childhood associated with aspirin-exacerbated respiratory disease

Research examines novel treatment techniques for hemophilia B, VTE

Research examines novel treatment techniques for hemophilia B, VTE

Aspirin decreases risk of major complications from cardiac surgery

Aspirin decreases risk of major complications from cardiac surgery

Novartis to showcase 160 presentations on breast cancer, hematological disease drugs at SABCS and ASH

Novartis to showcase 160 presentations on breast cancer, hematological disease drugs at SABCS and ASH

Treatments for lymphoma with no side effects

Treatments for lymphoma with no side effects

Study reveals classification scheme for treatment of blunt aortic injury

Study reveals classification scheme for treatment of blunt aortic injury

Just a few drugs responsible for majority of emergency hospitalizations

Just a few drugs responsible for majority of emergency hospitalizations

Study examines how mice with genetic bone defects respond to infusions of BMMSC

Study examines how mice with genetic bone defects respond to infusions of BMMSC

NYU Langone cardiovascular experts present new research findings at AHA 2011

NYU Langone cardiovascular experts present new research findings at AHA 2011

Optimal approach to treat patients without known coronary disease much less clear

Optimal approach to treat patients without known coronary disease much less clear

Calcium scoring test may predict risk of heart disease

Calcium scoring test may predict risk of heart disease

Drug-coated balloon restores blood flow in narrowed bare metal stent

Drug-coated balloon restores blood flow in narrowed bare metal stent

Dipyrone may reduce brain damage after stroke

Dipyrone may reduce brain damage after stroke

Combination of antipsychotic and antidepressant drugs may increase risk of CV mortality

Combination of antipsychotic and antidepressant drugs may increase risk of CV mortality

POZEN reports positive Phase 1 study results comparing PA32540 to clopidogrel for CVDs

POZEN reports positive Phase 1 study results comparing PA32540 to clopidogrel for CVDs

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.